HCA
HCA Healthcare, Inc. · Healthcare · Medical Care Facilities
Last
$529.71
+$3.83 (+0.73%) 4:00 PM ET
Prev close $525.88
Open $523.50
Day high $532.63
Day low $523.50
Volume 1,813,372
Avg vol 1,228,141
Mkt cap
$118.45B
P/E ratio
18.69
FY Revenue
$75.60B
EPS
28.34
Gross Margin
100.00%
Sector
Healthcare
AI report sections
HCA
HCA Healthcare, Inc.
HCA combines solid multi-period price appreciation and positive momentum signals with overbought technical readings and a stretched position versus key moving averages. Fundamentally, the company shows steady revenue, earnings, and cash flow growth with healthy margins and free cash flow generation but operates with very high leverage, minimal equity, and tight liquidity ratios. Valuation appears moderate on earnings and cash flow metrics while the balance sheet structure and elevated short-volume activity introduce non-trivial risk considerations.
AI summarized at 10:51 AM ET, 2026-01-27
AI summary scores
INTRADAY: 63 SWING: 71 LONG: 77
Volume vs average
Intraday (cumulative)
+99% (Above avg)
Vol/Avg: 1.99×
RSI
55.99 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.30 (Weak)
MACD: -0.55 Signal: -0.25
Short-Term
+0.03 (Strong)
MACD: 12.72 Signal: 12.68
Long-Term
+2.21 (Strong)
MACD: 15.26 Signal: 13.04
Intraday trend score 68.01

Latest news

HCA 12 articles Positive: 7 Neutral: 5 Negative: 0
Positive The Motley Fool • Jonathan Ponciano
This Fund Sold $38 Million in Appian Stock Last Quarter. Shares Have Fallen Over 25% This Year

Abdiel Capital Advisors sold 1,075,738 shares of Appian (worth $38.32 million) in Q4 2025, reducing its stake to 12.4% of assets. Appian shares have fallen 28.1% over the past year and underperformed the S&P 500 by 39.1 percentage points. Despite the reduction, Abdiel maintains a double-digit allocation, suggesting risk management rather than abandonment of the investment thesis.

APPN HCA GLBE AFRM fund selling stock decline low-code automation enterprise software
Sentiment note

Listed as Abdiel Capital's top holding at 44.2% of AUM ($31.39 million), indicating strong confidence and allocation priority within the fund's portfolio.

Positive The Motley Fool • Prosper Junior Bakiny
1 Unstoppable Healthcare Stock to Buy and Hold

HCA Healthcare, a major medical facilities operator, delivered strong Q4 2025 results with 6.7% revenue growth and 28.8% EPS growth. Despite modest 3.5% revenue guidance for 2026 due to expired premium tax credits and regulatory uncertainty, the company is well-positioned for long-term growth driven by aging populations and AI-enhanced healthcare initiatives.

HCA healthcare stocks HCA Healthcare medical facilities earnings growth regulatory uncertainty aging population artificial intelligence in healthcare
Sentiment note

Strong Q4 2025 financial performance with 6.7% revenue growth and 28.8% EPS jump. Stock up 7% YTD in 2026. Company demonstrates resilience amid regulatory challenges and has significant long-term growth opportunities from aging populations and AI-driven initiatives. Analyst recommends holding for long-term above-average returns despite near-term volatility.

Positive The Motley Fool • Prosper Junior Bakiny
2 High-Flying Growth Stocks to Buy and Hold for 10 Years

The article recommends Robinhood Markets and HCA Healthcare as strong 10-year investment opportunities. Robinhood is positioned to benefit from its popularity among younger investors and expanding services including AI tools and prediction markets, despite valuation concerns and crypto volatility. HCA Healthcare is well-positioned to capitalize on demographic shifts as the aging population increases healthcare demand, with a diversified payer mix helping mitigate reimbursement risks.

HOOD HCA growth stocks long-term investing commission-free trading cryptocurrency healthcare demographic shift
Sentiment note

Well-positioned to benefit from aging U.S. population increasing healthcare demand through 2036; demonstrated ability to grow market share over 15 years; diversified payer mix reduces reimbursement risk; strong 2025 performance with higher service utilization and favorable reimbursement rates.

Positive Benzinga • Eva Mathew
OpenAI Buys Healthcare Startup Torch Days After Launching ChatGPT Health

OpenAI acquired healthcare startup Torch for approximately $60-100 million, days after launching ChatGPT Health. Torch was designed as a unified medical memory platform consolidating patient data from hospitals, labs, and wearables. The four-person team will join OpenAI as part of the acquisition. This move is part of OpenAI's broader expansion into healthcare with enterprise-grade products for health systems like HCA Healthcare.

HCA OpenAI Torch acquisition ChatGPT Health healthcare technology medical data AI in healthcare HCA Healthcare
Sentiment note

HCA Healthcare is mentioned as an initial partner for OpenAI's healthcare products, positioning the company to benefit from advanced AI-powered healthcare solutions and potentially improving operational efficiency.

Neutral The Motley Fool • Josh Kohn-Lindquist
Darsana Capital Opens New $189 Million Wingstop Position: Is the Stock a Buy?

Darsana Capital initiated a new $189 million stake in Wingstop, purchasing 750,000 shares representing 4.45% of their portfolio. Despite recent same-store sales declines, the investment suggests potential long-term growth in the restaurant chain.

WING SATS GWRE NYT Wingstop investment restaurant franchise
Sentiment note

Mentioned as a top holding but no specific analysis provided

Neutral Investing.com • Nabeel Bukhari
Why Tenet Healthcare Could Be the Sector’s Big Winner

Tenet Healthcare demonstrates strong financial performance with impressive Q2 2025 results, featuring revenue growth, margin expansion, and strategic focus on ambulatory care. The company shows potential for growth despite potential future Medicaid policy challenges.

THC HCA CYH healthcare ambulatory care Medicaid share buybacks margin expansion
Sentiment note

Consistent revenue growth but more expensive valuation compared to Tenet, with lower EBITDA margins and growth rates

Neutral The Motley Fool • Josh Kohn-Lindquist
Abdiel Capital Liquidates Massive $113 Million Floor & Decor Stake: Should Investors Follow Suit?

Abdiel Capital fully exited its position in Floor & Decor Holdings, selling 1,482,936 shares worth $112.64 million, reducing its assets under management and potentially signaling concerns about the company's performance and housing market conditions.

FND HCA GLBE AFRM Floor & Decor stock liquidation housing market investment strategy
Sentiment note

Remains top holding for Abdiel Capital at $147.60 million, representing 44.7% of assets under management

Positive Benzinga • Vandana Singh
America's Leading Hospital Operator HCA Healthcare Outperforms Citing Solid Patient Volumes

HCA Healthcare reported strong Q3 2025 financial results, with revenues of $19.16 billion (9.6% YoY increase) and adjusted earnings of $6.96. The hospital operator saw growth in patient admissions, surgeries, and raised its fiscal year 2025 guidance.

HCA healthcare hospital earnings patient volume revenue
Sentiment note

Exceeded analyst expectations, increased revenues, raised fiscal year guidance, reported growth in patient admissions and surgeries, and saw stock trading at a 52-week high

Positive The Motley Fool • Prosper Junior Bakiny
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade

Two healthcare companies, HCA Healthcare and TransMedics Group, show promising long-term potential due to their innovative strategies, market positioning, and ability to adapt to industry changes.

HCA TMDX healthcare organ transplantation medical technology hospital services
Sentiment note

Consistently increasing market share, strong financial performance, extensive facility network, and high barriers to entry in the healthcare industry

Neutral Benzinga • Akanksha Bakshi
Premier Set For Private Ownership, Eyes Growth Push

Premier Inc. will be acquired by Patient Square Capital for $28.25 per share, representing a 23.8% premium to its 60-day average closing price. The deal aims to improve financial flexibility and accelerate investments in technology and services.

PINC HCA UNH acquisition healthcare private ownership investment
Sentiment note

Mentioned in article but not directly involved in the transaction

Neutral GlobeNewswire Inc. • Dr. Matthew Albert
EndoQuest Advances Multicenter PARADIGM Trial with Completion of Procedure at AdventHealth Orlando

EndoQuest Robotics is conducting a multicenter clinical trial (PARADIGM Trial) to evaluate its Endoluminal Surgical (ELS) System for minimally invasive colorectal lesion removal across five U.S. healthcare institutions.

HCA robotic surgery endoscopic submucosal dissection colorectal surgery minimally invasive procedure
Sentiment note

Participating in clinical trial as a research site

Positive Investing.com • Sam Quirke
Can HCA Healthcare Revive the Market’s Weakest Sector?

HCA Healthcare demonstrates strong performance in a struggling healthcare sector, outperforming market trends with a 14% gain in 2025, driven by strategic acquisitions and robust financial results.

HCA UNH healthcare sector performance earnings acquisitions market trends
Sentiment note

Reported Q2 EPS of $6.84 vs expectations of $6.20, revenues of $18.61 billion, 6th consecutive quarterly beat, 13.1% net income increase, forecasting 12.21% EPS growth next year

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal